NZ231131A - An ophthalmic cyclosporin composition - Google Patents

An ophthalmic cyclosporin composition

Info

Publication number
NZ231131A
NZ231131A NZ231131A NZ23113189A NZ231131A NZ 231131 A NZ231131 A NZ 231131A NZ 231131 A NZ231131 A NZ 231131A NZ 23113189 A NZ23113189 A NZ 23113189A NZ 231131 A NZ231131 A NZ 231131A
Authority
NZ
New Zealand
Prior art keywords
composition according
component
present
amount
vherein
Prior art date
Application number
NZ231131A
Other languages
English (en)
Inventor
Ronald Edward Peeples
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of NZ231131A publication Critical patent/NZ231131A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
NZ231131A 1988-10-26 1989-10-25 An ophthalmic cyclosporin composition NZ231131A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26286688A 1988-10-26 1988-10-26

Publications (1)

Publication Number Publication Date
NZ231131A true NZ231131A (en) 1992-06-25

Family

ID=22999400

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ231131A NZ231131A (en) 1988-10-26 1989-10-25 An ophthalmic cyclosporin composition

Country Status (23)

Country Link
JP (1) JPH02164830A (enExample)
KR (1) KR900005973A (enExample)
AU (1) AU626928B2 (enExample)
BE (1) BE1003578A4 (enExample)
CA (1) CA2001502A1 (enExample)
CH (1) CH679210A5 (enExample)
DE (1) DE3935517A1 (enExample)
DK (1) DK531289A (enExample)
ES (1) ES2020032A6 (enExample)
FI (1) FI895064A7 (enExample)
FR (1) FR2638089A1 (enExample)
GB (1) GB2224205B (enExample)
GR (1) GR1000611B (enExample)
HU (1) HU203046B (enExample)
IL (1) IL92120A (enExample)
LU (1) LU87613A1 (enExample)
MY (1) MY106271A (enExample)
NL (1) NL8902657A (enExample)
NO (1) NO894266L (enExample)
NZ (1) NZ231131A (enExample)
PT (1) PT92120B (enExample)
SE (1) SE8903583L (enExample)
ZA (1) ZA898140B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
CA2002147A1 (en) * 1988-11-07 1990-05-07 Shuichi Morikawa Production process for polyimide fibers
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
FR2670629B1 (fr) * 1990-12-17 1995-03-10 Moving Magnet Tech Actionneur electromagnetique monophase rotatif.
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
DK0642332T3 (da) * 1992-05-13 1997-06-16 Sandoz Ltd Ophthalmiske præparater indeholdende cyclosporin
US5366739A (en) * 1992-08-06 1994-11-22 Deo Corporation Method of ophthalmic drug delivery
US5830508A (en) * 1992-08-06 1998-11-03 Deo Corporation Composition for treating dry eye
ES2168271T3 (es) 1992-09-25 2002-06-16 Novartis Ag Composiciones farmaceuticas que contienen ciclosporinas.
US5698533A (en) * 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
PT789580E (pt) 1994-11-03 2002-09-30 Novartis Ag Formulacoes de ciclosporina para administracao oral com composicao simples e alta biodisponibilidade e processo para a sua producao
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
KR20040004416A (ko) 1997-01-30 2004-01-13 노파르티스 아게 오일을 함유하지 않은 사이클로스포린 ａ 함유 제약 조성물
US6254860B1 (en) * 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives
US7557082B2 (en) * 2006-03-03 2009-07-07 Allergan, Inc. Treatment with cyclosporin A
SG185955A1 (en) * 2007-11-05 2012-12-28 Bausch & Lomb Water-immiscible materials as vehicles for drug delivery
HRP20171691T1 (hr) * 2009-06-05 2017-12-15 Allergan, Inc. Umjetne suze i njihova upotreba u terapiji
RU2697844C9 (ru) 2014-11-25 2019-10-01 Аллерган, Инк. Стабилизированные композиции для офтальмологического применения, содержащие омега-3-кислоты
KR102288022B1 (ko) 2016-12-23 2021-08-10 노바리크 게엠베하 건성 안 질환 치료용 안구 조성물
MX2022002667A (es) 2019-09-06 2022-04-07 Novaliq Gmbh Composicion oftalmica para el tratamiento de uveitis.
EP4201398A1 (en) * 2021-12-24 2023-06-28 Isoxa S.r.l. Isocyclosporin a for topical treatment of ocular diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin

Also Published As

Publication number Publication date
KR900005973A (ko) 1990-05-07
AU626928B2 (en) 1992-08-13
DK531289D0 (da) 1989-10-25
LU87613A1 (fr) 1991-05-07
NL8902657A (nl) 1990-05-16
CH679210A5 (enExample) 1992-01-15
HU203046B (en) 1991-05-28
SE8903583D0 (sv) 1989-10-26
DE3935517A1 (de) 1990-05-03
GB2224205B (en) 1992-04-15
NO894266L (no) 1990-04-27
HU895444D0 (en) 1990-01-28
GB8924040D0 (en) 1989-12-13
IL92120A0 (en) 1990-07-12
PT92120A (pt) 1990-04-30
FI895064A7 (fi) 1990-04-27
DK531289A (da) 1990-04-27
ZA898140B (en) 1991-06-26
GR1000611B (el) 1992-08-31
GB2224205A (en) 1990-05-02
NO894266D0 (no) 1989-10-26
HUT52394A (en) 1990-07-28
SE8903583L (sv) 1990-04-27
MY106271A (en) 1995-04-29
FR2638089A1 (fr) 1990-04-27
JPH02164830A (ja) 1990-06-25
GR890100690A (en) 1990-11-29
AU4371589A (en) 1990-05-03
CA2001502A1 (en) 1990-04-26
IL92120A (en) 1994-02-27
PT92120B (pt) 1995-06-30
ES2020032A6 (es) 1991-07-16
BE1003578A4 (fr) 1992-04-28
FI895064A0 (fi) 1989-10-25

Similar Documents

Publication Publication Date Title
AU626928B2 (en) Cyclosporin opthalmic compositions
IT8948485A1 (it) Composizioni oftalmiche a base di una ciclosporina (caso 600-7089)
US5951971A (en) Ophthalmic compositions
Constad et al. Use of an angiotensin converting enzyme inhibitor in ocular hypertension and primary open-angle glaucoma
US6579901B2 (en) Pharmaceutical compositions and methods for treating immune-response associated diseases of the surface and the anterior segment of the eye
US5294604A (en) Method of treating ocular diseases by periocular administration of cyclosporine A or G
KR20070094600A (ko) 안질환 치료제
SK171798A3 (en) Topical preparations containing immunosuppressive agents
US20250134881A1 (en) Treatment of ocular inflammatory diseases using laquinimod
JP2022546980A (ja) ブドウ膜炎の治療のための眼科用組成物
CN1216469A (zh) 含有二氢吡啶类化合物的眼组织末梢循环改善剂
JPH08508975A (ja) 眼科薬送達ビヒクルとしてのサブミクロン乳剤
Grehn et al. Thymoxamine: a miotic for intraocular use
JP2632010B2 (ja) シクロスポリン製剤
STEWART Review timolol hemihydrate: A new formulation of Timolol for the treatment of glaucoma
Fallor et al. Ocular toxicity of experimental intravitreal vitamin E
Lewis et al. Aminozolamide suspension: the role of the vehicle in a topical carbonic anhydrase inhibitor
ZALTA et al. The effect of nitroglycerin ointment on the external ocular structures of rabbits
Polak Drugs used in ocular treatment